These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2854736)

  • 41. [Plasmapheresis in neurology -- personal experience].
    Załeska B; Domzał T; Korsak J
    Neurol Neurochir Pol; 1994; 28(2):167-74. PubMed ID: 8047226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasmapheresis in Guillain-Barré syndrome.
    Dyck PJ; Kurtzke JF
    Neurology; 1985 Aug; 35(8):1105-7. PubMed ID: 4022343
    [No Abstract]   [Full Text] [Related]  

  • 43. [Plasmapheresis and hormone therapy in severe forms of Guillain-Barré syndrome].
    Levchenko NI; Piradov MA; Pirogov VN
    Klin Med (Mosk); 1989 Dec; 67(12):88-91. PubMed ID: 2560799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Guillain-Barré syndrome in childhood. Characteristic course and therapeutic possibilities].
    Korinthenberg R; Sauer M
    Monatsschr Kinderheilkd; 1992 Nov; 140(11):792-8. PubMed ID: 1335122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome.
    Gürses N; Uysal S; Cetinkaya F; Işlek I; Kalayci AG
    Scand J Infect Dis; 1995; 27(3):241-3. PubMed ID: 8539548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Landry Guillain-Barré Strohl syndrome in pregnancy: report of three cases treated with plasmapheresis.
    Hurley TJ; Brunson AD; Archer RL; Lefler SF; Quirk JG
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):482-5. PubMed ID: 1870800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasmapheresis in acute Guillain-Barre' syndrome.
    Morosetti M; Meloni C; Meschini L; Taccone-Gallucci M; Di Giulio S; Bernardi G; Casciani C
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(2):213-9. PubMed ID: 8318613
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome.
    Koski CL; Gratz E; Sutherland J; Mayer RF
    Ann Neurol; 1986 Jun; 19(6):573-7. PubMed ID: 3729311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guillain-Barré syndrome and cytomegalovirus infection during pregnancy.
    Mendizabal JE; Bassam BA
    South Med J; 1997 Jan; 90(1):63-4. PubMed ID: 9003827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
    Tagawa Y; Yuki N
    Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Motor conduction studies in Guillain-Barré syndrome: description and prognostic value.
    Cornblath DR; Mellits ED; Griffin JW; McKhann GM; Albers JW; Miller RG; Feasby TE; Quaskey SA
    Ann Neurol; 1988 Apr; 23(4):354-9. PubMed ID: 3382170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Manual plasmapheresis in the treatment of Guillain-Barré syndrome.
    de Zoysa NS; Jayaweera KK; Vaithianathan T
    J Clin Apher; 1994; 9(2):147-50. PubMed ID: 7798165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasmapheresis for Guillain-Barré syndrome.
    Storgion SA; Igarashi M; May WN; Stidham GL
    Pediatr Neurol; 1989; 5(6):389-90. PubMed ID: 2604804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The value of plasmapheresis in the treatment of acute and chronic Guillain-Barré syndrome.
    Kunze K; Emskötter T
    J Neuroimmunol; 1988 Dec; 20(2-3):301-3. PubMed ID: 3198753
    [No Abstract]   [Full Text] [Related]  

  • 55. Oculomotor effects of intermittent conduction block in myasthenia gravis and Guillain-Barré syndrome. An oculographic study with computer simulations.
    Feldon SE; Stark L; Lehman SL; Hoyt WF
    Arch Neurol; 1982 Aug; 39(8):497-503. PubMed ID: 6285871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute "axonal" Guillain-Barré syndrome in childhood.
    Reisin RC; Cersósimo R; García Alvarez M; Massaro M; Fejerman N
    Muscle Nerve; 1993 Dec; 16(12):1310-6. PubMed ID: 8232386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Plasmapheresis therapy in Guillain-Barré polyneuroradiculitis].
    Zwahlen H; Quadri F; Mombelli G; Tatti V; Marone C
    Schweiz Med Wochenschr; 1988 Dec; 118(49):1854-8. PubMed ID: 3217776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunoadsorption with PH-350: as a beneficial therapy for acute Guillain-Barre syndrome.
    Ishida H; Shimizu Y; Imada K; Itagaki T; Urushidani Y; Shimoyama R; Oono Y
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):267-75. PubMed ID: 1751676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt.
    Saad K; Mohamad IL; Abd El-Hamed MA; Tawfeek MS; Ahmed AE; Abdel Baseer KA; El-Shemy AS; El-Houfey AA; Tamer DM
    Ther Adv Neurol Disord; 2016 Jan; 9(1):3-8. PubMed ID: 26788127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guillain-Barré syndrome and plasmapheresis in childhood.
    Ann Neurol; 1991 Jun; 29(6):688-9. PubMed ID: 1892374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.